PharmacyCodes



(-)-L-Carnitin en es it fr

(-)-L-Carnitin Brand names, (-)-L-Carnitin Analogs

(-)-L-Carnitin Brand Names Mixture

  • No information avaliable

(-)-L-Carnitin Chemical_Formula

C16H16ClN3O4

(-)-L-Carnitin RX_link

http://www.rxlist.com/cgi/generic/loracarb.htm

(-)-L-Carnitin fda sheet

(-)-L-Carnitin msds (material safety sheet)

(-)-L-Carnitin MSDS

(-)-L-Carnitin Synthesis Reference

No information avaliable

(-)-L-Carnitin Molecular Weight

349.769 g/mol

(-)-L-Carnitin Melting Point

No information avaliable

(-)-L-Carnitin H2O Solubility

No information avaliable

(-)-L-Carnitin State

Solid

(-)-L-Carnitin LogP

0.286

(-)-L-Carnitin Dosage Forms

No information avaliable

(-)-L-Carnitin Indication

Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

(-)-L-Carnitin Pharmacology

Loracarbef is considered a second generation cephalosporin antibiotic. The advantages of cephalosporin antibiotics include a broad range of activity, a safe record in children with almost no dose-related toxicity, and the lack of need to monitor levels. Adverse reactions are rare and consist primarily of hypersensitivity reactions with urticaria, nonspecific rash, and pruritus. Loracarbef can be used to treat a large number of bacterial infections caused by gram-negative and gram-positive bacteria, including upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

(-)-L-Carnitin Absorption

Well absorbed with approximately 90% absorbed from the gastrointestinal tract after oral ingestion.

(-)-L-Carnitin side effects and Toxicity

Adverse effects include diarrhea, nausea, stomach upset, vomiting, headache, dizziness, rash, bone marrow depression.

(-)-L-Carnitin Patient Information

http://www.drugs.com/MTM/lomefloxacin.html

(-)-L-Carnitin Organisms Affected

Many kinds of gram-negative and gram-positive eubacteria